homoeriodictyol has been researched along with quercetin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Augereau, JM; Billon, M; Gleye, J; Herbert, JM; Lale, A; Leconte, M | 1 |
| Chen, J; Dong, X; Hu, Y; Jiang, C; Qi, L; Wei, E | 1 |
| Itoh, T; Sakakibara, H; Shimoi, K; Takemura, H; Yamamoto, K | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Bicknell, KA; Farrimond, JA; Putnam, SE; Swioklo, S; Watson, KA; Williamson, EM | 1 |
| Dutour, R; Poirier, D | 1 |
| Li, GH; Li, YR; Lou, HX; Ren, DM; Shen, T; Wang, XN; Xiang, L; Zhou, MX | 1 |
| Andrews, PK; Davies, NM; Ohgami, Y; Remsberg, CM; Takemoto, JK; Vega-Villa, KR; Yáñez, JA | 1 |
1 review(s) available for homoeriodictyol and quercetin
| Article | Year |
|---|---|
Inhibitors of cytochrome P450 (CYP) 1B1.
Topics: Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Structure-Activity Relationship | 2017 |
7 other study(ies) available for homoeriodictyol and quercetin
| Article | Year |
|---|---|
Ability of different flavonoids to inhibit the procoagulant activity of adherent human monocytes.
Topics: Amino Acid Sequence; Blood Coagulation; Cell Adhesion; Endotoxins; Flavonoids; Humans; In Vitro Techniques; Interleukin-1; Molecular Sequence Data; Monocytes | 1996 |
Synthesis, biological evaluation of prenylflavonoids as vasorelaxant and neuroprotective agents.
Topics: Animals; Aorta; Chromones; Flavonoids; Neuroprotective Agents; PC12 Cells; Rats; Structure-Activity Relationship; Vasodilation | 2009 |
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.
Topics: Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Flavonoids; Humans; Models, Molecular; Structure-Activity Relationship | 2010 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
Topics: Cell Differentiation; Flavonoids; Humans; Mesenchymal Stem Cells; Molecular Structure; Osteogenesis; Signal Transduction; Structure-Activity Relationship | 2015 |
Discovery of natural flavonoids as activators of Nrf2-mediated defense system: Structure-activity relationship and inhibition of intracellular oxidative insults.
Topics: Arsenic; Biological Products; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Discovery; Epithelial Cells; Flavonoids; Humans; Molecular Structure; NF-E2-Related Factor 2; Structure-Activity Relationship | 2018 |
Stereospecific pharmacokinetics of racemic homoeriodictyol, isosakuranetin, and taxifolin in rats and their disposition in fruit.
Topics: Animals; Area Under Curve; Chromatography, High Pressure Liquid; Drug Stability; Flavones; Flavonoids; Fruit; Half-Life; Male; Molecular Structure; Quercetin; Rats; Rats, Sprague-Dawley; Serum; Stereoisomerism; Urine | 2011 |